Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3356016 | 0.85 | CES1 (0.34) | ALDH1A1 | |
| SCHEMBL3351523 | 0.78 | CYP1A2 (0.43) | ALDH1A1LMNA | |
| SCHEMBL6630016 | 0.69 | ALDH1A1 (0.41) | ALDH1A1LMNA | |
| SCHEMBL27411717 | 0.69 | ALDH1A1 (0.41) | ALDH1A1LMNA | |
| SCHEMBL3128733 | 0.68 | PIK3C3 (0.35) | ALDH1A1LMNA | |
| SCHEMBL6602469 | 0.68 | HTR2B (0.39) | ALDH1A1LMNA | |
| SCHEMBL303734 | 0.67 | — | — | |
| SCHEMBL22598045 | 0.65 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL23592889 | 0.65 | — | — | |
| SCHEMBL709372 | 0.65 | ALDH1A1 (0.52) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1395251-A2 | AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-03-10 | — | — | EP | disclosed |
| WO-2002100818-A2 | AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | disclosed |